Barclays analyst Lauren Lieberman maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and raises the price target from $71 to $74.
How To Align Medical Marijuana Strains With Specific Conditions: Learn From Dr. Chanda Macias, Scientist, Researcher And Cannabis Pioneer
July 24, 1:00 PM
Dr. Chanda Macias is a trailblazer in the legal cannabis industry many times over.
July 22, 12:22 PM
Morgan Stanley analysts Kimberley Greenberger, Pam Kaufman, and John Glass saw initial signs of low-income and increasingly middle-income consumer pressure in the first half of FY22. Now, Morgan Stanley economists have also flagged rising recession risk.
July 21, 2:22 PM
Analysts have provided the following ratings for Colgate-Palmolive (NYSE:CL) within the last quarter:
July 14, 10:39 AM
On Wednesday, shares of Colgate-Palmolive Company (NYSE: CL) experienced volatile short activity. After the activity, the stock price went up +0.15% to $78.43. The overall sentiment for CL has been Bearish.
June 13, 9:11 AM
Colgate-Palmolive's (NYSE:CL) short percent of float has fallen 5.03% since its last report. The company recently reported that it has 14.22 million shares sold short, which is 1.7% of all regular shares that are available for trading.
June 9, 11:25 AM
If history is any guide, there may be good fortune ahead for shares of Colgate-Palmolive (NYSE:CL). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.